Hibiscus Capital Management
North America, Maryland, United States, Rockville
Description
Hibiscus Capital Management is a subsidiary of transformative biotechnology commercially viable technologies.
Investor Profile
Hibiscus Capital Management has made 2 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (50%)
- Series C (50%)
Country Focus
- United States (50%)
- China (50%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Health Diagnostics
- Therapeutics
- Dietary Supplements
- Manufacturing
- Nutrition
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
